Integrin α4 and CCR5 direct IFN-γ–activated MSCs to the gut and associated lymphoid tissue enabling effective GVHD prophylaxis

1. γMSC trafficking to GVHD tissues is essential for prevention, while monocytes/macrophages are needed for γMSC function, not for trafficking. 2. γMSC trafficking to GVHD tissues relies on integrin α4β1–MAdCAM-1 adhesion and CCR5-driven chemotaxis toward inflammatory chemokines. Interferon-γ-activated mesenchymal stromal cells (γMSCs) exhibit potent immunosuppressive properties; yet nonactivated MSCs remain the focus of clinical trials. Murine studies have shown that γMSCs can prevent acute graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HCT), but the site of immunomodulatory activity and the molecular mechanisms directing their distribution remain unclear. Using a mouse model of acute GVHD, human γMSC infused 24 hours after HCT localized primarily in the gut, gut-associated lymphoid tissue (GALT), liver, and spleen, but not skin draining lymph nodes (SDLN), sites comparable with the cellular initiation of GVHD. In vitro, γMSC adhered preferentially to spleen endothelial cells compared to SDLN endothelium. Integrin α4 knockdown and anti-MAdCAM-1 blocking antibody reduced binding to spleen endothelial cells by 94% and 48%, respectively. Activated T cells upregulated CCL3, CCL4, and CCL5, and blocking these chemokines together abolished γMSC migration. γMSC expressed CCR5 was upregulated upon exposure to activated T cell media and CCR5 knockdown reduced in vitro migration by 90%. In vivo , knockdown of α4 or CCR5 impaired γMSC trafficking to GALT and significantly reduced GVHD prophylaxis, although T cell suppression in vitro was retained. Finally, depletion of monocytes/macrophages by liposomal clodronate did not affect γMSC trafficking but abolished the GVHD-suppressive activity of γMSC, indicating that macrophages are not required for γMSC trafficking, but essential for their therapeutic function. Our study reveals that the coordinated expression of integrin α4 and CCR5 on γMSC governs their trafficking where they exert their immunosuppressive effect and significantly reduce GVHD in a murine model.

Authors

Institutions

Publication Details

Journal
Blood Immunology & Cellular Therapy
Published
2025-11-14
DOI
https://doi.org/10.1016/j.bict.2025.100017
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrin α4 and CCR5 direct IFN-γ–activated MSCs to the gut and associated lymphoid tissue enabling effective GVHD prophylaxis

Andre J. Burnham, Kyndal Goss, Elisabetta Manuela Foppiani, Swathi Shrihari et al.
Blood Immunology & Cellular Therapy
Mesenchymal stem cell research
article

Integrin α4 and CCR5 direct IFN-γ–activated MSCs to the gut and associated lymphoid tissue enabling effective GVHD prophylaxis

Andre J. Burnham, Kyndal Goss, Elisabetta Manuela Foppiani, Swathi Shrihari, Rebecca E. Burnham, Massimo Dominici, A. Albright, Sarah Romanelli, Edwin M. Horwitz, Pratik A. Patel, Lisa P. Daley‐Bauer, Scott E. Gillespie
article en

Abstract

1. γMSC trafficking to GVHD tissues is essential for prevention, while monocytes/macrophages are needed for γMSC function, not for trafficking. 2. γMSC trafficking to GVHD tissues relies on integrin α4β1–MAdCAM-1 adhesion and CCR5-driven chemotaxis toward inflammatory chemokines. Interferon-γ-activated mesenchymal stromal cells (γMSCs) exhibit potent immunosuppressive properties; yet nonactivated MSCs remain the focus of clinical trials. Murine studies have shown that γMSCs can prevent acute graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HCT), but the site of immunomodulatory activity and the molecular mechanisms directing their distribution remain unclear. Using a mouse model of acute GVHD, human γMSC infused 24 hours after HCT localized primarily in the gut, gut-associated lymphoid tissue (GALT), liver, and spleen, but not skin draining lymph nodes (SDLN), sites comparable with the cellular initiation of GVHD. In vitro, γMSC adhered preferentially to spleen endothelial cells compared to SDLN endothelium. Integrin α4 knockdown and anti-MAdCAM-1 blocking antibody reduced binding to spleen endothelial cells by 94% and 48%, respectively. Activated T cells upregulated CCL3, CCL4, and CCL5, and blocking these chemokines together abolished γMSC migration. γMSC expressed CCR5 was upregulated upon exposure to activated T cell media and CCR5 knockdown reduced in vitro migration by 90%. In vivo , knockdown of α4 or CCR5 impaired γMSC trafficking to GALT and significantly reduced GVHD prophylaxis, although T cell suppression in vitro was retained. Finally, depletion of monocytes/macrophages by liposomal clodronate did not affect γMSC trafficking but abolished the GVHD-suppressive activity of γMSC, indicating that macrophages are not required for γMSC trafficking, but essential for their therapeutic function. Our study reveals that the coordinated expression of integrin α4 and CCR5 on γMSC governs their trafficking where they exert their immunosuppressive effect and significantly reduce GVHD in a murine model.

Blood Immunology & Cellular TherapyVol. 2(1)
University of Modena and Reggio Emilia (IT), Emory University (US), Children's Healthcare of Atlanta (US)
Openalex Percentile: Top 50%
Mesenchymal stem cell research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.